Skip to content

Zimmer Biomet Holdings

US · ZBH #1040 by market cap Listed 1970
101.10 -0.37 -0.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 101.70 +0.23%
After-hours 100.82 -0.28%
110.1581.89101.102026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ZBH?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +8.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has fallen to 4.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 25.5x Better than 29%
Forward P/E 19.1x Better than 41%
Price / Sales 2.3x Better than 52%
P/E vs own 5-yr range 53rd pctl Better than 57%
Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 5.9% Better than 50%
Net income CAGR (3Y) 45.0% Better than 86%
Free cash flow CAGR (3Y) 10.0% Better than 52%
Profitability B

How much profit the business keeps from each dollar of sales and capital.

Gross margin 69.7% Better than 83%
Operating margin 16.5% Better than 69%
Net margin 8.6% Better than 55%
Return on equity 5.6% Better than 38%
Return on invested capital 4.9% Better than 44%
Momentum A-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 0.4% Better than 74%
6-month return 18.9% Better than 82%
12-month return (ex latest month) 8.3% Better than 44%
Distance below 52-week high 10.2% Better than 83%
Financial Health B

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.0x Better than 55%
Debt to assets 32.6% Better than 37%
Interest coverage 3.8x Better than 50%
Free cash flow / net income 201.4% Better than 77%
Analyst View D

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 26.7% Better than 13%
Upside to average target 13.3% Better than 20%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -2.04%
1M +5.31%
3M +2.43%
6M +19.04%
YTD +13.33%
1Y +14.72%
3Y -7.56%
5Y -15.51%

Key statistics

Price & volume

Prev close
101.47
Open
102.72
Day range
100.82 - 103.87
Avg price
101.70
Volume
2.96M
Turnover
300.98M
Amplitude
3.00%
52-week range
78.70 - 112.55

Valuation

P/E
28.48
P/E (TTM)
25.53
P/B
1.50
EPS
3.55
Net profit
671.85M
Net assets
12.72B

Share structure

Market cap
19.13B
Float cap
19.07B
Shares out
189.25M
Float shares
188.65M

Dividend & listing

Dividend (TTM)
0.96
Listing date
1970-01-01
52-week range 66% of range
78.70 112.55

10.2% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+11.17M net over the window

Short interest

Shares short
7.85M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Zimmer Biomet Holdings (ZBH)?

Zimmer Biomet Holdings last traded at 101.10. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Zimmer Biomet Holdings's market cap?

About 19.13B.

What is the P/E ratio of Zimmer Biomet Holdings?

The trailing twelve-month P/E is 25.53, below its own 5-year average of 46.33 — in the middle of its historical range (53.07% percentile). See the Valuation tab for the full history.

Does Zimmer Biomet Holdings pay a dividend?

Yes. The trailing dividend yield is 0.95%. Per-share dividends have risen or held for 10 straight years through 2025. See the Dividends tab for the full payment history.

Is Zimmer Biomet Holdings a buy according to analysts?

The consensus of 15 analysts is a Buy rating, with an average 12-month price target of 114.50, which implies 13.3% upside from the current price. This is not investment advice.

What is Zimmer Biomet Holdings's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Zimmer Biomet Holdings a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Zimmer Biomet Holdings discussion 0 comments

Add a comment